A significant shift in Canadian drug policy has occurred, as the authorities permit the legalization of psilocybin mushrooms for therapeutic purposes. Previously, these substances were strictly restricted, but a mounting body of research suggests they potentially offer benefits for mental health conditions like anxiety. The new policy represents a